View in EDS HTML Full Text PDF Full Text

Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.

Saved in:
Bibliographic Details
Title: Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.
Authors: van Keulen AM; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Buettner S; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Olthof PB; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. p.olthof@erasmusmc.nl., Klümpen HJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Erdmann JI; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Izquierdo-Sanchez L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III' (ISCIII), CIBERehd, Madrid, Spain., Banales JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.; National Institute for the Study of Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III' (ISCIII), CIBERehd, Madrid, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.; Basque Foundation for Science, Bilbao, Spain., Goeppert B; Institute of Pathology and Neuropathology, RKH Klinikum Ludwigsburg, Ludwigsburg, Germany.; Institute of Pathology, Kantonsspital Baselland, Liestal, Switzerland.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Roessler S; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Zieniewicz K; Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland., Lamarca A; Department of Oncology - OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain.; Department of Medical Oncology, The Christie NHS Foundation, Manchester, England.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Valle JW; Department of Medical Oncology, The Christie NHS Foundation, Manchester, England.; Division of Cancer Sciences, University of Manchester, Manchester, UK., La Casta A; Medical Oncology Department, OSI Donostialdea/Biodonostia, San Sebastián, Spain., Hoogwater FJH; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Donadon M; Department of Hepatobiliary and General Surgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Scheiter A; Institute of Pathology, University of Regensburg, Regensburg, Germany., Marzioni M; Clinic of Gastroenterology and Hepatology, Universita Politecnica delle Marche, Ancona, Italy., Adeva J; Department of Medical Oncology, Hospital Universitario, 12 de Octubre, Madrid, Spain., Kiudeliene E; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania., Fernández JMU; Servicio de Aparato Digestivo, Complejo Hospitalario de Navarra, Pamplona, Navarra, España., Vidili G; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.; Department of Internal Medicine, Day Hospital of the Medical Area, Azienda Ospedaliero Universitaria, AOU, Sassari, Italy., Mocan T; Babeș-Bolyai University - UBB Med Department, Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania., Fabris L; Department of Molecular Medicine, University of Padua School of Medicine, Padua, Italy.; Digestive Disease Section, Yale University School of Medicine, New Haven, CT, USA., Krawczyk M; Laboratory of Metabolic Liver Diseases, Medical University of Warsaw, Warsaw, Poland.; Department of Medicine II, Saarland University Medical Center, Homburg, Germany., Folseraas T; Section of Gastroenterology and the Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway., Dopazo C; Department of HPB Surgery and Transplants, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autónoma de Barcelona, Barcelona, Spain., Detry O; Department of Abdominal Surgery and Transplantation, CHU Liege, University of Liege, Liege, Belgium., Voiosu T; Gastroenterology Department, Faculty of Medicine, Colentina Clinical Hospital, UMF Carol Davila, Bucharest, Romania., Scripcariu V; University of Medicine and Pharmacy 'Gr T Popa', Regional Institute of Oncology, Iasi, Romania., Biancaniello F; Department of Translational and Precision Medicine, Sapienza' University of Rome, Rome, Italy., Braconi C; Royal Marsden NHS Trust, London, Surrey, UK.; Beatson West of Scotland Cancer Centre, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Macias RIR; Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, University of Salamanca, IBSAL, CIBERehd, Salamanca, Spain., Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Oct; Vol. 31 (10), pp. 6495-6503. Date of Electronic Publication: 2024 Jun 19.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1534-4681
DOI:10.1245/s10434-024-15582-5